Hemithyroidectomy or total thyroidectomy for low-risk papillary thyroid cancer?
Tóm tắt
Từ khóa
Tài liệu tham khảo
Adam MA, Pura J, Goffredo P et al (2015) Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years. J Clin Endocrinol Metab 100:115–121
Adam MA, Pura J, Gu L et al (2014) Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients. Ann Surg 260:601–605
Ahmadi S, Gonzalez JM, Talbott M et al (2020) Patient Preferences Around Extent of Surgery in Low-Risk Thyroid Cancer: A Discrete Choice Experiment. Thyroid 30:1044–1052
Al Afif A, Williams BA, Rigby MH et al (2015) Multifocal Papillary Thyroid Cancer Increases the Risk of Central Lymph Node Metastasis. Thyroid 25:1008–1012
Al-Qurayshi Z, Nilubol N, Tufano RP et al (2020) Wolf in Sheep’s Clothing: Papillary Thyroid Microcarcinoma in the US. J Am Coll Surg 230:484–491
American Thyroid Association Guidelines Taskforce on Thyroid N, Differentiated Thyroid C, Cooper DS et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214
Back K, Kim SK, Chai YJ et al (2019) Does microscopic positive tumor margin in papillary thyroid cancer really matter? Surgery 166:1160–1167
Bakkar S, Al-Omar K, Donatini G et al (2021) Postoperatively determined high-risk histopathologic features in papillary thyroid carcinoma initially eligible for thyroid lobectomy: a game changer. Endocrine 74:611–615
Baloch ZW, Asa SL, Barletta JA et al (2022) Overview of the 2022 WHO Classification of Thyroid Neoplasms. Endocr Pathol 33:27–63
Baloch ZW, Harrell RM, Brett EM et al (2017) Managing Thyroid Tumors Diagnosed as Non-Invasive Follicular Tumor with Papillary Like Nuclear Features (Niftp). Endocr Pract. https://doi.org/10.4158/EP171940.DC
Barbesino G, Goldfarb M, Parangi S et al (2012) Thyroid lobe ablation with radioactive iodine as an alternative to completion thyroidectomy after hemithyroidectomy in patients with follicular thyroid carcinoma: long-term follow-up. Thyroid 22:369–376
Bardet S, Ciappuccini R, Quak E et al (2015) Prognostic value of microscopic lymph node involvement in patients with papillary thyroid cancer. J Clin Endocrinol Metab 100:132–140
Barney BM, Hitchcock YJ, Sharma P et al (2011) Overall and cause-specific survival for patients undergoing lobectomy, near-total, or total thyroidectomy for differentiated thyroid cancer. Head Neck 33:645–649
Beal SH, Chen SL, Schneider PD et al (2010) An evaluation of lymph node yield and lymph node ratio in well-differentiated thyroid carcinoma. Am Surg 76:28–32
Bergenfelz A, Nordenstrom E, Almquist M (2020) Morbidity in patients with permanent hypoparathyroidism after total thyroidectomy. Surgery 167:124–128
Bilimoria KY, Bentrem DJ, Ko CY et al (2007) Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 246:375–381
Billroth T (1969) Chirurgische Erfahrung. Zürich. 1860–1867. Langenbecks Archive für klinische. Chirurgie 10:158–171
Buttner M, Locati LD, Pinto M et al (2020) Quality of Life in Patients With Hypoparathyroidism After Treatment for Thyroid Cancer. J Clin Endocrinol Metab. https://doi.org/10.1210/clinem/dgaa597
Cady B, Sedgwick CE, Meissner WA et al (1976) Changing clinical, pathologic, therapeutic, and survival patterns in differentiated thyroid carcinoma. Ann Surg 184:541–553
Capdevila J, Awada A, Fuhrer-Sakel D et al (2022) Molecular diagnosis and targeted treatment of advanced follicular cell-derived thyroid cancer in the precision medicine era. Cancer Treat Rev 106:102380
Carty SE, Doherty GM, Inabnet WB 3rd et al (2012) American Thyroid Association statement on the essential elements of interdisciplinary communication of perioperative information for patients undergoing thyroid cancer surgery. Thyroid 22:395–399
Chan S, Karamali K, Kolodziejczyk A et al (2020) Systematic Review of Recurrence Rate after Hemithyroidectomy for Low-Risk Well-Differentiated Thyroid Cancer. Eur Thyroid J 9:73–84
Cho SY, Lee TH, Ku YH et al (2015) Central lymph node metastasis in papillary thyroid microcarcinoma can be stratified according to the number, the size of metastatic foci, and the presence of desmoplasia. Surgery 157:111–118
Cho U, Mete O, Kim MH et al (2017) Molecular correlates and rate of lymph node metastasis of non-invasive follicular thyroid neoplasm with papillary-like nuclear features and invasive follicular variant papillary thyroid carcinoma: the impact of rigid criteria to distinguish non-invasive follicular thyroid neoplasm with papillary-like nuclear features. Mod Pathol 30:810–825
Choi JB, Lee SG, Kim MJ et al (2019) Oncologic outcomes in patients with 1‑cm to 4‑cm differentiated thyroid carcinoma according to extent of thyroidectomy. Head Neck 41:56–63
Chou R, Dana T, Brent GA et al (2022) Serum Thyroglobulin Measurement Following Surgery Without Radioactive Iodine for Differentiated Thyroid Cancer: A Systematic Review. Thyroid 32:613–639
Chung R, Guan H, Ponchiardi C et al (2021) Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: Epidemiology and Long-Term Outcomes in a Strictly Defined Cohort. Thyroid 31:68–75
Colombo C, Muzza M, Proverbio MC et al (2019) Impact of Mutation Density and Heterogeneity on Papillary Thyroid Cancer Clinical Features and Remission Probability. Thyroid 29:237–251
Davies L, Hoang JK (2021) Thyroid cancer in the USA: current trends and outstanding questions. Lancet Diabetes Endocrinol 9:11–12
Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 295:2164–2167
Deng Y, Li H, Wang M et al (2020) Global Burden of Thyroid Cancer From 1990 to 2017. Jama Netw Open 3:e208759
Di Filippo L, Giugliano G, Tagliabue M et al (2020) Total thyroidectomy versus lobectomy: surgical approach to T1–T2 papillary thyroid cancer. Acta Otorhinolaryngol Ital 40:254–261
Diker-Cohen T, Hirsch D, Shimon I et al (2018) Impact of Minimal Extra-Thyroid Extension in Differentiated Thyroid Cancer: Systematic Review and Meta-analysis. J Clin Endocrinol Metab. https://doi.org/10.1210/jc.2018-00081
Dos Reis LL, Tuttle RM, Alon E et al (2014) What is the gold standard for comprehensive interinstitutional communication of perioperative information for thyroid cancer patients? A comparison of existing electronic health records with the current American Thyroid Association recommendations. Thyroid 24:1466–1472
Dralle H, Lorenz K, Machens A (2011) State of the art: surgery for endemic goiter—a plea for individualizing the extent of resection instead of heading for routine total thyroidectomy. Langenbecks Arch Surg 396:1137–1143
Dralle H, Machens A (2010) European endocrine surgery in the 150-year history of Langenbeck’s Archives of Surgery. Langenbecks Arch Surg 395 Suppl 1:43–55
Dralle H, Machens A, Basa J et al (2015) Follicular cell-derived thyroid cancer. Nat Rev Dis Primers 1:15077
Dralle H, Musholt TJ, Schabram J et al (2013) German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors. Langenbecks Arch Surg 398:347–375
Ebina A, Sugitani I, Fujimoto Y et al (2014) Risk-adapted management of papillary thyroid carcinoma according to our own risk group classification system: is thyroid lobectomy the treatment of choice for low-risk patients? Surgery 156:1579–1588
Eskander A, Hall SF, Manduch M et al (2019) A Population-Based Study on NIFTP Incidence and Survival: Is NIFTP Really a „Benign“ Disease? Ann Surg Oncol 26:1376–1384
Feng JW, Qu Z, Qin AC et al (2020) Significance of multifocality in papillary thyroid carcinoma. Eur J Surg Oncol 46:1820–1828
Forleo R, Grani G, Alfo M et al (2021) Minimal Extrathyroidal Extension in Predicting 1‑Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4). Thyroid 31:1814–1821
Franssila KO, Harach HR (1986) Occult papillary carcinoma of the thyroid in children and young adults. A systemic autopsy study in Finland. Cancer 58:715–719
Frey S, Figueres L, Pattou F et al (2021) Impact of Permanent Post-thyroidectomy Hypoparathyroidism on Self-evaluation of Quality of Life and Voice: Results From the National QoL-Hypopara Study. Ann Surg 274:851–858
Gemsenjager E (1993) Goiter surgery from Kocher to today. Schweiz Med Wochenschr 123:207–213
Glockzin G, Hornung M, Kienle K et al (2012) Completion thyroidectomy: effect of timing on clinical complications and oncologic outcome in patients with differentiated thyroid cancer. World J Surg 36:1168–1173
Goffredo P, Cheung K, Roman SA et al (2013) Can minimally invasive follicular thyroid cancer be approached as a benign lesion?: a population-level analysis of survival among 1,200 patients. Ann Surg Oncol 20:767–772
Gulec SA, Ahuja S, Avram AM et al (2021) A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the European Thyroid Association, the Society of Nuclear Medicine and Molecular Imaging on Current Diagnostic and Theranostic Approaches in the Management of Thyroid Cancer. Thyroid 31:1009–1019
Haigh PI, Urbach DR, Rotstein LE (2005) Extent of thyroidectomy is not a major determinant of survival in low- or high-risk papillary thyroid cancer. Ann Surg Oncol 12:81–89
Harach HR, Franssila KO, Wasenius VM (1985) Occult papillary carcinoma of the thyroid. A „normal“ finding in Finland. A systematic autopsy study. Cancer 56:531–538
Harries V, Wang LY, Mcgill M et al (2020) Should multifocality be an indication for completion thyroidectomy in papillary thyroid carcinoma? Surgery 167:10–17
Haugen BR, Alexander EK, Bible KC et al (2016) 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26:1–133
Haugen BR, Sawka AM, Alexander EK et al (2017) American Thyroid Association Guidelines on the Management of Thyroid Nodules and Differentiated Thyroid Cancer Task Force Review and Recommendation on the Proposed Renaming of Encapsulated Follicular Variant Papillary Thyroid Carcinoma Without Invasion to Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features. Thyroid 27:481–483
Holoubek SA, Yan H, Khokar AH et al (2020) Aggressive variants of papillary thyroid microcarcinoma are associated with high-risk features, but not decreased survival. Surgery 167:19–27
Hughes DT, Haymart MR, Miller BS et al (2011) The most commonly occurring papillary thyroid cancer in the United States is now a microcarcinoma in a patient older than 45 years. Thyroid 21:231–236
Iacobone M, Jansson S, Barczynski M et al (2014) Multifocal papillary thyroid carcinoma—a consensus report of the European Society of Endocrine Surgeons (ESES). Langenbecks Arch Surg 399:141–154
Imai T, Kitano H, Sugitani I et al (2013) Does total (or near total) thyreoidectomy improve the prognosis of papillary carcinoma patients compared to lobectomy or lobectomy isthmectomy ? Springer Japan
Ito Y, Fukushima M, Tomoda C et al (2009) Prognosis of patients with papillary thyroid carcinoma having clinically apparent metastasis to the lateral compartment. Endocr J 56:759–766
Ito Y, Fukushima M, Yabuta T et al (2009) Local prognosis of patients with papillary thyroid carcinoma who were intra-operatively diagnosed as having minimal invasion of the trachea: a 17-year experience in a single institute. Asian J Surg 32:102–108
Ito Y, Jikuzono T, Higashiyama T et al (2006) Clinical significance of lymph node metastasis of thyroid papillary carcinoma located in one lobe. World J Surg 30:1821–1828
Ito Y, Tomoda C, Uruno T et al (2006) Minimal extrathyroid extension does not affect the relapse-free survival of patients with papillary thyroid carcinoma measuring 4 cm or less over the age of 45 years. Surg Today 36:12–18
Jegerlehner S, Bulliard JL, Aujesky D et al (2017) Overdiagnosis and overtreatment of thyroid cancer: A population-based temporal trend study. PLoS ONE 12:e179387
Jensen CB, Saucke MC, Francis DO et al (2020) From Overdiagnosis to Overtreatment of Low-Risk Thyroid Cancer: A Thematic Analysis of Attitudes and Beliefs of Endocrinologists, Surgeons, and Patients. Thyroid 30:696–703
Jeon MJ, Kim HK, Kim EH et al (2018) Decreasing Disease-Specific Mortality of Differentiated Thyroid Cancer in Korea: A Multicenter Cohort Study. Thyroid 28:1121–1127
Jeon YW, Gwak HG, Lim ST et al (2019) Long-Term Prognosis of Unilateral and Multifocal Papillary Thyroid Microcarcinoma After Unilateral Lobectomy Versus Total Thyroidectomy. Ann Surg Oncol 26:2952–2958
Ji YB, Song CM, Kim D et al (2019) Efficacy of hemithyroidectomy in papillary thyroid carcinoma with minimal extrathyroidal extension. Eur Arch Otorhinolaryngol 276:3435–3442
Jorgensen CU, Homoe P, Dahl M et al (2021) Postoperative Chronic Hypoparathyroidism and Quality of Life After Total Thyroidectomy. Jbmr Plus 5:e10479
Kausch W (1910) Beidseitige Resektion oder einseitige Extirpation des Kropfes. Archiv für klinische. Chirurgie 98:829–856
Kiernan CM, Parikh AA, Parks LL et al (2015) Use of radioiodine after thyroid lobectomy in patients with differentiated thyroid cancer: does it change outcomes? J Am Coll Surg 220:617–625
Kim HJ, Sohn SY, Jang HW et al (2013) Multifocality, but not bilaterality, is a predictor of disease recurrence/persistence of papillary thyroid carcinoma. World J Surg 37:376–384
Kim J, Gosnell JE, Roman SA (2020) Geographic influences in the global rise of thyroid cancer. Nat Rev Endocrinol 16:17–29
Kim MJ, Lee MC, Lee GH et al (2017) Extent of surgery did not affect recurrence during 7‑years follow-up in papillary thyroid cancer sized 1–4 cm: Preliminary results. Clin Endocrinol (oxf) 87:80–86
Kitahara CM, Sosa JA, Shiels MS (2020) Influence of Nomenclature Changes on Trends in Papillary Thyroid Cancer Incidence in the United States, 2000 to 2017. J Clin Endocrinol Metab. https://doi.org/10.1210/clinem/dgaa690
Kocher T (1883) Über Kropfexstirpation und ihre Folgen. Archiv für klinische. Chirurgie 29:254–337
Kuba S, Yamanouchi K, Hayashida N et al (2017) Total thyroidectomy versus thyroid lobectomy for papillary thyroid cancer: Comparative analysis after propensity score matching: A multicenter study. Int J Surg 38:143–148
Kuo EJ, Goffredo P, Sosa JA et al (2013) Aggressive variants of papillary thyroid microcarcinoma are associated with extrathyroidal spread and lymph-node metastases: a population-level analysis. Thyroid 23:1305–1311
Kwon H, Jeon MJ, Kim WG et al (2017) A comparison of lobectomy and total thyroidectomy in patients with papillary thyroid microcarcinoma: a retrospective individual risk factor-matched cohort study. Eur J Endocrinol 176:371–378
Leboulleux S, Rubino C, Baudin E et al (2005) Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab 90:5723–5729
Leboulleux S, Bournaud C, Chougnet CN, et al (2022) Thyreoidectomy without Radioiodine in Low-Risk Thyroid Cancer. N Engl J Med. 286(10):923–932. https://doi.org/10.1056/NEJMoa2111953
Lee CR, Son H, Lee S et al (2014) Lobectomy and prophylactic central neck dissection for papillary thyroid microcarcinoma: do involved lymph nodes mandate completion thyroidectomy? World J Surg 38:872–877
Lee YM, Park JH, Cho JW et al (2019) The definition of lymph node micrometastases in pathologic N1a papillary thyroid carcinoma should be revised. Surgery 165:652–656
Lennquist S (1987) The thyroid nodule. Diagnosis and surgical treatment. Surg Clin North Am 67:213–232
Lenschow C, Mader U, Germer CT et al (2019) The time point of completion thyroidectomy has no prognostic impact in patients with differentiated thyroid cancer. Clin Endocrinol (oxf) 90:479–486
Li M, Brito JP, Vaccarella S (2020) Long-Term Declines of Thyroid Cancer Mortality: An International Age-Period-Cohort Analysis. Thyroid 30:838–846
Li M, Dal Maso L, Vaccarella S (2020) Global trends in thyroid cancer incidence and the impact of overdiagnosis. Lancet Diabetes Endocrinol 8:468–470
Liu W, Yan X, Cheng R (2020) Continuing controversy regarding individualized surgical decision-making for patients with 1–4 cm low-risk differentiated thyroid carcinoma: A systematic review. Eur J Surg Oncol 46:2174–2184
Lloyd RV (2017) TNM-KLassifikation maligner Tumoren, 8. Aufl. Wiley
Lücke G (1880) Abschnitt IV, Krankheiten der Schilddrüse in Handbuch der allgemeinen und speziellen Chirurgie mit Einschluss der topographischen Anatomie, Operations- und Verbandslehre. S. 1-99 Edt. Pitha F, Billroth T, Agatz GJ. urn:nbn:de:hbz:38m:1-79654
Luster M, Aktolun C, Amendoeira I et al (2019) European perspective on 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: proceedings of an interactive international symposium. Thyroid 29:7–26
Machens A, Dralle H (2015) Breach of the thyroid capsule and lymph node capsule in node-positive papillary and medullary thyroid cancer: different biology. Eur J Surg Oncol 41:766–772
Machens A, Dralle H (2012) Correlation between the number of lymph node metastases and lung metastasis in papillary thyroid cancer. J Clin Endocrinol Metab 97:4375–4382
Machens A, Lorenz K, Weber F et al (2021) Exceptionality of Distant Metastasis in Node-Negative Hereditary and Sporadic Medullary Thyroid Cancer: Lessons Learned. J Clin Endocrinol Metab 106:e2968–e2979
Machens A, Lorenz K, Weber F et al (2022) Risk Patterns of Distant Metastases in Follicular, Papillary and Medullary Thyroid Cancer. Horm Metab Res 54:7–11
Mainthia R, Wachtel H, Chen Y et al (2018) Evaluating the projected surgical impact of reclassifying noninvasive encapsulated follicular variant of papillary thyroid cancer as noninvasive follicular thyroid neoplasm with papillary-like nuclear features. Surgery 163:60–65
Matsuura D, Yuan A, Harris V et al (2022) Surgical Management of Low‑/Intermediate-Risk Node Negative Thyroid Cancer: A Single-Institution Study Using Propensity Matching Analysis to Compare Thyroid Lobectomy and Total Thyroidectomy. Thyroid 32:28–36
Megwalu UC, Moon PK (2022) Thyroid Cancer Incidence and Mortality Trends in the United States: 2000–2018. Thyroid 32:560–570
Mendelsohn AH, Elashoff DA, Abemayor E et al (2010) Surgery for papillary thyroid carcinoma: is lobectomy enough? Arch Otolaryngol Head Neck Surg 136:1055–1061
Mikulicz J (1886) Beitrag zur Operation des Kropfes. Wien Med Wochenschr 1:1–6
Miranda-Filho A, Lortet-Tieulent J, Bray F et al (2021) Thyroid cancer incidence trends by histology in 25 countries: a population-based study. Lancet Diabetes Endocrinol 9:225–234
Morley S, Goldfarb M (2015) Support needs and survivorship concerns of thyroid cancer patients. Thyroid 25:649–656
Newman SK, Harries V, Wang L et al (2022) Invasion of a Recurrent Laryngeal Nerve from Small Well-Differentiated Papillary Thyroid Cancers: Patient Selection Implications for Active Surveillance. Thyroid 32:164–169
Nicholson KJ, Teng CY, Mccoy KL et al (2019) Completion thyroidectomy: A risky undertaking? Am J Surg 218:695–699
Nickel B, Howard K, Brito JP et al (2018) Association of Preferences for Papillary Thyroid Cancer Treatment With Disease Terminology: A Discrete Choice Experiment. JAMA Otolaryngol Head Neck Surg 144:887–896
Nickel B, Tan T, Cvejic E et al (2019) Health-Related Quality of Life After Diagnosis and Treatment of Differentiated Thyroid Cancer and Association With Type of Surgical Treatment. JAMA Otolaryngol Head Neck Surg 145:231–238
Nikiforov YE, Seethala RR, Tallini G et al (2016) Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors. JAMA Oncol 2:1023–1029
Nixon IJ, Ganly I, Patel SG et al (2012) Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy. Surgery 151:571–579
Nixon IJ, Shah JP, Zafereo M et al (2020) The role of radioactive iodine in the management of patients with differentiated thyroid cancer—An oncologic surgical perspective. Eur J Surg Oncol 46:754–762
Pacini F, Fuhrer D, Elisei R et al (2022) 2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer? Eur Thyroid J. https://doi.org/10.1530/ETJ-21-0046
Parente DN, Kluijfhout WP, Bongers PJ et al (2018) Clinical Safety of Renaming Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: Is NIFTP Truly Benign? World J Surg 42:321–326
Patel KN, Yip L, Lubitz CC et al (2020) The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults. Ann Surg 271:e21–e93
Perzik S (1976) The place of total thyroidectomy in the management of 909 patients with thyroid disease. Am J Surg 132:480–483
Piccardo A, Trimboli P, Bottoni G et al (2020) Radioiodine Ablation of Remaining Thyroid Lobe in Patients with Differentiated Thyroid Cancer Treated by Lobectomy: A Systematic Review and Metaanalysis. J Nucl Med 61:1730–1735
Pitoia F, Jerkovich F, Urciuoli C et al (2015) Implementing the Modified 2009 American Thyroid Association Risk Stratification System in Thyroid Cancer Patients with Low and Intermediate Risk of Recurrence. Thyroid 25:1235–1242
Pitt SC, Saucke MC, Roman BR et al (2021) The Influence of Emotions on Treatment Decisions About Low-Risk Thyroid Cancer: A Qualitative Study. Thyroid 31:1800–1807
Polat SB, Cakir B, Evranos B et al (2019) Preoperative predictors and prognosis of bilateral multifocal papillary thyroid carcinomas. Surg Oncol 28:145–149
Rajjoub SR, Yan H, Calcatera NA et al (2018) Thyroid lobectomy is not sufficient for T2 papillary thyroid cancers. Surgery 163:1134–1143
Rana C, Vuong HG, Nguyen TQ et al (2021) The Incidence of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: A Meta-Analysis Assessing Worldwide Impact of the Reclassification. Thyroid 31:1502–1513
Randle RW, Bushman NM, Orne J et al (2017) Papillary thyroid cancer: the good and bad of the „good cancer“. Thyroid 27:902–907
Randolph GW, Duh QY, Heller KS et al (2012) The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid 22:1144–1152
Reeve TS, Delbridge L, Cohen A et al (1987) Total thyroidectomy. The preferred option for multinodular goiter. Ann Surg 206:782–786
Riedel B (1905) Zur Technik der Kropfoperation. Dtsch Med Wschr 22:857–859
Robenshtok E, Neeman B, Reches L et al (2022) Adverse Histological Features of Differentiated Thyroid Cancer Are Commonly Found in Autopsy Studies: Implications for Treatment Guidelines. Thyroid 32:37–45
Robinson TJ, Thomas S, Dinan MA et al (2016) How Many Lymph Nodes Are Enough? Assessing the Adequacy of Lymph Node Yield for Papillary Thyroid Cancer. J Clin Oncol 34:3434–3439
Rodriguez Schaap PM, Botti M, Otten RHJ et al (2020) Hemithyroidectomy versus total thyroidectomy for well differentiated T1–2 N0 thyroid cancer: systematic review and meta-analysis. BJS Open. https://doi.org/10.1002/bjs5.50359
Saito Y, Matsuzu K, Sugino K et al (2019) The impact of completion thyroidectomy followed by radioactive iodine ablation for patients with lymph node recurrence of papillary thyroid carcinoma. Surgery 166:342–348
Sanabria A, Betancourt-Aguero C, Sanchez-Delgado JG et al (2022) Prophylactic Central Neck Lymph Node Dissection in Low-risk Thyroid Carcinoma Patients Does Not Decrease the Incidence of Locoregional Recurrence: A Meta-analysis of Randomized Trials. Ann Surg 276:66–73
Sanabria A, Rojas A, Arevalo J et al (2019) Microscopically positive surgical margins and local recurrence in thyroid cancer. A meta-analysis. Eur J Surg Oncol 45:1310–1316
Sawant R, Hulse K, Sohrabi S et al (2019) The impact of completion thyroidectomy. Eur J Surg Oncol 45:1171–1174
Scheffel RS, Zanella AB, Dora JM et al (2016) Timing of Radioactive Iodine Administration Does Not Influence Outcomes in Patients with Differentiated Thyroid Carcinoma. Thyroid 26:1623–1629
Scheumann GF, Seeliger H, Musholt TJ et al (1996) Completion thyroidectomy in 131 patients with differentiated thyroid carcinoma. Eur J Surg 162:677–684
Schmid KW, Synoracki S, Dralle H et al (2019) Proposal for an extended pTNM classification of thyroid carcinoma : Commentary on deficits of the 8th edition of the TNM classification. Pathologe 40:18–24
Seib CD, Sosa JA (2019) Evolving Understanding of the Epidemiology of Thyroid Cancer. Endocrinol Metab Clin North Am 48:23–35
Shaha AR, Poorten VV, Tuttle RM (2020) Multifocality in papillary thyroid carcinoma—An unresolved controversy. Eur J Surg Oncol 46:1777–1778
Sippel RS, Robbins SE, Poehls JL et al (2020) A Randomized Controlled Clinical Trial: No Clear Benefit to Prophylactic Central Neck Dissection in Patients With Clinically Node Negative Papillary Thyroid Cancer. Ann Surg 272:496–503
Song E, Han M, Oh HS et al (2019) Lobectomy Is Feasible for 1–4 cm Papillary Thyroid Carcinomas: A 10-Year Propensity Score Matched-Pair Analysis on Recurrence. Thyroid 29:64–70
Staubitz JI, Elmrich I, Musholt PB et al (2021) Targeted use of intraoperative frozen-section analysis lowers the frequency of completion thyroidectomy. Bjs Open. https://doi.org/10.1093/bjsopen/zraa058
Stern S, Hilly O, Horowitz E et al (2015) Is There Justification for Total Thyroidectomy in Low-Risk Papillary Thyroid Carcinoma? A Decision-Analysis Model. World J Surg 39:2707–2717
Sugitani I, Ito Y, Takeuchi D et al (2021) Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma. Thyroid 31:183–192
Sugitani I, Kasai N, Fujimoto Y et al (2004) A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery 135:139–148
Sung MW, Park B, An SY et al (2014) Increasing thyroid cancer rate and the extent of thyroid surgery in Korea. Plos One 9:e113464
Synoracki S, Ting S, Siebolts U et al (2015) Intraoperative frozen sections of the thyroid gland. Pathologe 36:362–371
Synoracki S, Wittekind C, Dralle H et al (2017) Definition of R1 resection in thyroid carcinoma. Chirurg 88:740–747
Tallini G, Tuttle RM, Ghossein RA (2017) The history of the follicular variant of papillary thyroid carcinoma. J Clin Endocrinol Metab 102:15–22
Tan MP, Agarwal G, Reeve TS et al (2002) Impact of timing on completion thyroidectomy for thyroid cancer. Br J Surg 89:802–804
Tanaka A, Matsuse M, Saenko V et al (2019) TERT mRNA Expression as a Novel Prognostic Marker in Papillary Thyroid Carcinomas. Thyroid 29:1105–1114
Theurer S, Dralle H, Fuhrer-Sakel D et al (2019) Morphologic diagnostic criteria of noninvasive follicular neoplasia with papillary-like nuclear features (NIFTP) : A diagnostic challenge for the patient’s benefit. Pathologe 40:220–226
Thompson LD (2016) Ninety-four cases of encapsulated follicular variant of papillary thyroid carcinoma: A name change to Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features would help prevent overtreatment. Mod Pathol 29:698–707
Tollefsen HR, Shah JP, Huvos AG (1972) Papillary carcinoma of the thyroid. Recurrence in the thyroid gland after initial surgical treatment. Am J Surg 124:468–472
Trimboli P, Piccardo A, Signore A et al (2020) Patient Age Is an Independent Risk Factor of Relapse of Differentiated Thyroid Carcinoma and Improves the Performance of the American Thyroid Association Stratification System. Thyroid 30:713–719
Tuttle RM, Ahuja S, Avram AM et al (2019) Controversies, Consensus, and Collaboration in the Use of (131)I Therapy in Differentiated Thyroid Cancer: A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid Association. Thyroid 29:461–470
Ullmann TM, Gray KD, Stefanova D et al (2019) The 2015 American Thyroid Association guidelines are associated with an increasing rate of hemithyroidectomy for thyroid cancer. Surgery 166:349–355
Vaccarella S, Franceschi S, Bray F et al (2016) Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis. N Engl J Med 375:614–617
Verburg FA, Aktolun C, Chiti A et al (2016) Why the European Association of Nuclear Medicine has declined to endorse the 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 43:1001–1005
Viola D, Materazzi G, Valerio L et al (2015) Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: clinical implications derived from the first prospective randomized controlled single institution study. J Clin Endocrinol Metab 100:1316–1324
Walgenbach S, Junginger T (2002) Is the timing of completion thyroidectomy for differentiated thyroid carcinoma prognostic significant? Zentralbl Chir 127:435–438
Wang F, Yu X, Shen X et al (2017) The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid Cancer. J Clin Endocrinol Metab 102:3241–3250
Wang LY, Ghossein R, Palmer FL et al (2015) Microscopic Positive Margins in Differentiated Thyroid Cancer Is Not an Independent Predictor of Local Failure. Thyroid 25:993–998
Watutantrige-Fernando S, Vianello F, Barollo S et al (2018) The Hobnail Variant of Papillary Thyroid Carcinoma: Clinical/Molecular Characteristics of a Large Monocentric Series and Comparison with Conventional Histotypes. Thyroid 28:96–103
Wei J, Thwin M, Nickel B et al (2022) Factors That Inform Individual Decision Making Between Active Surveillance, Hemithyroidectomy and Total Thyroidectomy for Low-Risk Thyroid Cancer: A Scoping. Rev Thyroid. https://doi.org/10.1089/thy.2021.0646
White C, Weinstein MC, Fingeret AL et al (2020) Is Less More? A Microsimulation Model Comparing Cost-effectiveness of the Revised American Thyroid Association’s 2015 to 2009 Guidelines for the Management of Patients With Thyroid Nodules and Differentiated Thyroid Cancer. Ann Surg 271:765–773
Wittekind C (2017) TNM Klassifikation maligner Tumoren, 8. Aufl. Wiley
Wittekind C (2012) Compton, Cc., Brierly, J., Sobin, Lh. Wiley-Blackwell, TNM Supplement
Wittekind C (2010) Meyer, Hj. Wiley-Blackwell, TNM-KLassifikation maligner Tumoren
Xu B, Tallini G, Scognamiglio T et al (2017) Outcome of Large Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features. Thyroid 27:512–517
Xu S, Huang H, Zhang X et al (2021) Predictive Value of Serum Thyroglobulin for Structural Recurrence Following Lobectomy for Papillary Thyroid Carcinoma. Thyroid 31:1391–1399
Xu Y, Huang K, Huang P et al (2021) Benefits and harms of hemithyroidectomy, total or near-total thyroidectomy in 1–4 cm differentiated thyroid cancer. Clin Endocrinol (oxf) 95:668–676
Yip L, Nikiforova MN, Yoo JY et al (2015) Tumor genotype determines phenotype and disease-related outcomes in thyroid cancer: a study of 1510 patients. Ann Surg 262:519–525
Yu XM, Schneider DF, Leverson G et al (2013) Follicular variant of papillary thyroid carcinoma is a unique clinical entity: a population-based study of 10,740 cases. Thyroid 23:1263–1268
Zaridze D, Maximovitch D, Smans M et al (2021) Thyroid cancer overdiagnosis revisited. Cancer Epidemiol 74:102014
Zhang C, Li Y, Li J et al. (2020) Total thyroidectomy versus lobectomy for papillary thyroid cancer: A systematic review and meta-analysis. Medicine (Baltimore) 99:e19073
Zhou L, Li H, Liang W et al (2020) Pretracheal-laryngeal lymph nodes in frozen section predicting contralateral paratracheal lymph nodes metastasis. Eur J Surg Oncol 46:1829–1834